Scott Kelly is an accomplished professional in the field of epidemiology and pharmacoepidemiology, currently serving as the Oncology Real-World Evidence & Epidemiology Group Lead at Pfizer since April 2020, overseeing a team of approximately 27 colleagues focused on oncology studies. Prior roles at Pfizer include Senior Director positions in both Pharmacoepidemiology Risk Contextualization and Vaccines and Anti-Infectives, where Scott led teams in supporting safety studies across various therapeutic areas. Previous experience includes serving as the Lead Epidemiologist for the American Academy of Ophthalmology, and postdoctoral and research fellow positions at the National Cancer Institute. Scott holds a PhD in Epidemiology from The George Washington University and an MS in Biostatistics/Epidemiology from Georgetown University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices